Emergent BioSolutions Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 6.81 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 349.17M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma ...